Enhancing the utility of ProstaScint SPECT scans for patient management

Journal of Medical Systems

Volumn 30, Issue 2, 2006, Pages 123-132

  Noz, Marilyn E ^a   Chung, Grace ^a   Lee, Benjamin Y ^a   Maguire Jr , Gerald Q ^b   DeWyngaert, J Keith ^a   Doshi, Jay V ^a   Kramer, Elissa L ^a   Murphy Walcott, Antoinette D ^a   Zeleznik, Michael P ^c   Kwak, Noeun G ^d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c RAHD Oncology Products   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

ProstaScint SPECT artifact elimination; Prostate cancer treatment planning; Reconstruction algorithms; Volume fusion; Volume subtraction

Indexed keywords

INDIUM 111; TECHNETIUM 99M;

AORTA; ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; EVALUATION; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARDIZATION; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PATIENT CARE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33746386932     PISSN: 01485598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10916-005-7987-y     Document Type: Article

References (38)

1. Eubank, W. B., Mankoff, D. A., Schmiedl, U. P., Winter, T. C. III, Fisher, E. R., Olshen, A. B., Graham, M. M., and Eary, J. F. Imaging of oncologic patients: Benefit of combined CT and FDG PET in the diagnosis of malignancy. Am. J. Roentgenol. 171:1103-1110, 1998.
2. Mizowaki, T., Cohen, G. N., Fung, A. Y., and Zaider, M. Towards integrating functional imaging in the treatment of prostate cancer with radiation: The registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 54:1558-1564, 2002.
3. Sannazzari, G. L., Ragona, R., Ruo Redda, M. G., Giglioli, F. R., Isolato, G., and Guarneri, A. CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br. J. Radiol. 75:603-607, 2002.
4. Wahl, R. L., Quint, L. E., Cieslak, R. D., Aisen, A. M., Koeppe, R. A., and Meyer, C. R. Anatometabolic tumor imaging: Fusion of FDG PET with CT or MRI to localize foci of increased activity. J. Nucl. Med. 34:1190-1197, 1993.
5. Wahl, R. L., Quint, L. E., Greenough, R., Meyer, C. R., White, R. I., and Orringer, M. B. Staging of mediastinum nonsmall cell lung cancer with FDG-PET, CT, and fusion images: Preliminary prospective evaluation. Radiology 191:371-377, 1994.
6. Kooy, H. M., Dunbar, S. F., Tarbell, N. J., Mannarino, E., Ferarro, N., Shusterman, S., Bellerive, M., Finn, L., McDonough, C. V., and Loeffler, J. S. Image fusion lor stereotactic radiotherapy and radiosurgery treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 28:1229-1234, 1994.
7. Schad, L. R., Boesecke, R., Schlegel, W., Hartmann, G. H., Sturm, V., Strauss, L. G., and Lorenz, W. J. Three-dimensional image correlation of CT, MR, and PET studies in radiotherapy treatment planning of brain tumors. J. Comput. Assist. Tomogr. 11:948-954, 1987.
8. Small, E. J. Advances in prostate cancer. Curr. Opin. Oncol. 11:226-235, 1999.
9. Murphy, G. P., Elgamal, A. A., Troychak, M. J., and Kenny, G. M. Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy. Prostate 42:315-317, 2000.
10. Petronis, J. D., Regan, F., and Lin, K. Indium-111 Capromab Pendetide (Prostascint) imaging to detect recurrent and metastatic prostate cancer. Clin. Nucl. Med. 23:672-677, 1998.
11. Hinkle, G. H., Burgers, J. K., Neal, C. E., Texter, J. H., Kahn, D., Williams, R. D., Maguire, R., Rogers, B., Olsen, J. O., and Badalament, R. A. Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using Indium-111 Capromab Pendetide. Cancer 83:739-747, 1998.
12. Manyak, M. J. Capromab Pendetide immunoscintigraphy: Connecting the dots for prostate cancer imaging. Cancer Biother. Radiopharm. 15:127-130, 2000.
13. Manyak, M. J., Hinkle, G. H., Olsen, J. O., Chiaccherini, R. P., Partin, A. W., Piantadosi, S., Burgers, J. K., Texter, J. H., Neal, C. E., Libertino, J. A., Wright, G. L. Jr., and Maguire, R. T. Immunoscintigraphy with Indium-111-Capromab Pendetide: Evaluation before definitive therapy in patients with prostate cancer. Urology 54:1058-1063, 1999.
14. Raj, G. V., Partin, A. W., and Polascik, T. J. Clinical utility of Indium 111-Capromab Pendetide immunoscintigraphy in the detection of early recurrent prostate carcinoma after radical prostate-ctomy. Cancer 94:987-996, 2002.
15. Rini, B. I., and Small, E. J. Prostate cancer update. Curr. Opin. Oncol. 14:288-291, 2002.
16. Cooperberg, M. R., Broering, J. M., Litwin, M. S., Lubeck, D. P., Mehta, S. S., Henning, J. M., Carroll, P. R., and CaPSURE Investigators. The Contemporary Management of prostate cancer in the United States: Lessons from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a National Disease Registry. J. Urol. 171:1393-1401, 2004.
17. Quintana, J. C., and Blend, M. J. The dual-isotope prostascint imaging procedure: Clinical experience and staging results in 145 patients. Clin. Nucl. Med. 25:33-46, 200.
18. Long, D. T., King, M. A., and Sheehan, J. Comparative evaluation of image segmentation methods for volume quantization in SPECT. Med. Phys. 19:483-489, 1992.
19. King, M. A., Long, D. T., and Brill, A. B. SPECT volume quantization: Influence of spatial resolution, source size and shape, and voxel size. Med. Phys. 18:1016-1024, 1991.
20. Hamilton, R. J., Blend, M. J., Pelizzari, C. A., Milliken, B. D., and Vijayakumar, S. Using vascular structure for CT-SPECT registration in the pelvis. J. Nucl. Med. 40:347-351, 1999.
21. Thomas, C. T., Bradshaw, P. T., Pollock, B. H., Montie, J. E., Taylor, J. M. G., Thames, H. D., McLaughlin, P. W., deBiose, D. A., Hussey, D. H., and Wahl, R. L. Indium-111-Capromab Pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy. J. Clin. Oncol. 21:1715-1721, 2003.
22. Schettino, C. J., Kramer, E. L., Noz, M. E., Taneja, S., Padmanabhan, P., and Lepor, H. Impact of fusion of Indium-111 Capromab Pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer. Am. J. Roentgenol. 183:519-524, 2004.
23. Ellis, R. J., Kim, E. Y., Conant, R., Sodee, D. B., Spirnak, J. P., Dinchman, K. H., Beddar, S., Wessels, B., Resnick, M. I., and Kinsella, T. J. Radioimmunoguided imaging of prostate cancer foci with histopathological correlation. Int. J. Radiat. Oncol. Biol. Phys. 49:1281-1286, 2001.
24. Sodee, D. B., Ellis, R. J., Samuels, M. A., Spirnak, J. P., Poole, W. F., Riester, C., Martanovic, D. M., Stonecipher, R., and Bellon, E. M. Prostate cancer and prostate bed SPECT imaging with Prostascint: Semiquantitative correlation with prostatic biopsy results. Prostate 37:140-148, 1998.
25. Ellis, R. J., Sodee, D. B., Spirnak, J. P., Dinchman, K. H., O'Leary, A. W., Samuels, M. A., Resnick, M. I., and Kinsella, T. J. Feasibility and acute toxicities of radioimmunoguided prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 48:683-687, 2000.
26. Duchesne, G. M. Radiation for prostate cancer. Lancet Oncol. 2:73-81, 2001.
27. Bruyant, P. B. Analytic and iterative reconstruction algorithms in SPECT. J. Nucl. Med. 43:1343-1358, 2002.
28. Riddell, C., Carson, R. E., Carrasquillo, J. A., Libutti, S. K., Danforth, D. N., Whatley, M., and Bacharach, S. L. Noise reduction in oncology DFG PET images by iterative reconstruction: A quantitative assessment. J. Nucl. Med. 42:1316-1323, 2001.
29. deJonge, F. A. A., and Blokland, K. A. K. Statistical tomographic reconstruction: How many more iterations to go? Eur. J. Nucl. Med. Mol. Imaging 26:1247-1250, 1999.
30. Lee, B. Y., deWyngaert, J. K., Noz, M. E., Maguire, G. Q. Jr., Murphy-Walcott, A., and Kramer, E. L. Unmasking true signal/tumor information from ProstaScint scans. Proc. SPIE Med. Imaging SPIE - Int. Soc. Opt. Eng. 5370:1980-1990, 2004.
31. Reddy, D. P., Maguire, G. Q. Jr., Noz, M. E., and Kenny, R. Automating image format conversion - Twelve years and twenty-five formats later. In Lemke, H. U., Inamura, K., Jaffee, C. C., and Felix, R. (eds.), Computer-Assisted Radiology - CAR'93, Springer-Verlag, Berlin, pp. 253-258, 1993.
32. Noz, M. E., Maguire, G. Q. Jr., Zeleznik, M. P., Kramer, E. L., Mahmoud, F., and Crafoord, J. A versatile functional-anatomic image fusion method for volume data sets. J. Med. Syst. 25:297-307, 2001.
33. Gomiak, R. J., Kramer, E. L., Maguire, G. Q. Jr., Noz, M. E., Schettino, C. J., and Zeleznik, M. P. Evaluation of a semiautomatic 3D fusion technique applied to molecular imaging and MRI brain/frame volume data sets. J. Med. Syst. 27:141-156, 2003.
34. deWyngaert, J. K., Noz, M. E., Ellerin, B., Kramer, E. L., Maguire, G. Q. Jr., and Zeleznik, M. P. Procedure for unmasking localization information from ProstaScint scans for prostate radiation therapy treatment. Int. J. Radiat. Oncol. Biol. Phys. 60:654-662, 2004.
35. Maguire, G. Q. Jr., Noz, M. E., Rusinek, H., Jaeger, J., Kramer, E. L., Sanger, J. J., and Smith, G. Graphics applied to image registration. IEEE Comput. Graphics Appl. 11:20-29, 1991.
36. Cohen, J., Statistical Power Analysis for the Behavioral Sciences, 2nd edn., Erlbaum, Hillside, NJ, 1988.
37. vandenberghe, S., D'Asseler, Y., van de Walle, R., et al. Iterative reconstruction algorithms in nuclear medicine. Comput. Med. Imaging Graphics 25:105-111, 2001.
38. Erdi, Y. E., Wessels, B. W., Loew, M. H., and Erdi, A. K. Threshold estimation in single emission computed tomography and planar imaging for clinical radioimmunotherapy. Cancer Res. 55(Suppl.):5823-5826, 1995.